Publications found:
33,058
Sort by:
2014 Market Research Report on Global Metronidazole Industry
US$ 2,850.00
'2014 Market Research Report on Global Metronidazole Industry' was a professional and depth research report on Global Metronidazole industry that you would ... and assistance from Metronidazole industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Norfloxacin Industry
US$ 2,850.00
'2014 Market Research Report on Global Norfloxacin Industry' was a professional and depth research report on Global Norfloxacin industry that you would know ... and assistance from Norfloxacin industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Ofloxacin Industry
US$ 2,850.00
'2014 Market Research Report on Global Ofloxacin Industry' was a professional and depth research report on Global Ofloxacin industry that you would know ... support and assistance from Ofloxacin industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Oxacillin Industry
US$ 2,850.00
'2014 Market Research Report on Global Oxacillin Industry' was a professional and depth research report on Global Oxacillin industry that you would know ... support and assistance from Oxacillin industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Penicillin G Industry
US$ 2,850.00
'2014 Market Research Report on Global Penicillin G Industry' was a professional and depth research report on Global Penicillin G industry that you would know ... and assistance from Penicillin G industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Penicillin Industrial Salt Industry
US$ 2,850.00
'2014 Market Research Report on Global Penicillin Industrial Salt Industry' was a professional and depth research report on Global Penicillin Industrial Salt ... from Penicillin Industrial Salt industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Spiramycin Industry
US$ 2,850.00
'2014 Market Research Report on Global Spiramycin Industry' was a professional and depth research report on Global Spiramycin industry that you would know the ... and assistance from Spiramycin industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Streptomycin Industry
US$ 2,850.00
'2014 Market Research Report on Global Streptomycin Industry' was a professional and depth research report on Global Streptomycin industry that you would know ... and assistance from Streptomycin industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Sulfadiazine Industry
US$ 2,850.00
'2014 Market Research Report on Global Sulfadiazine Industry' was a professional and depth research report on Global Sulfadiazine industry that you would know ... and assistance from Sulfadiazine industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global Tetracycline Industry
US$ 2,850.00
'2014 Market Research Report on Global Tetracycline Industry' was a professional and depth research report on Global Tetracycline industry that you would know ... and assistance from Tetracycline industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...
March 2014
176 pages
2014 Market Research Report on Global T-Octylammonium Clavulanate Industry
US$ 2,850.00
'2014 Market Research Report on Global T-Octylammonium Clavulanate Industry' was a professional and depth research report on Global T-Octylammonium Clavulanate industry that ... T-Octylammonium Clavulanate industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the ...
March 2014
176 pages
Investigation Report on China Valsartan Hydrochlorothiazide Market, 2009-2018
US$ 1,800.00
... Produced by Different Enterprises in China Hospital Market Sales Value of Valsartan Hydrochlorothiazide in China Hospital Market Major Valsartan Hydrochlorothiazide Manufacturers in China Prospect of China Valsartan Hydrochlorothiazide Market The following enterprises and people are recommended to ...
March 2014
40 pages
Investigation Report on China Adalimumab Market, 2010-2018
US$ 1,800.00
... of Adalimumab in Hospital Market in China Price of Adalimumab Produced by Vetter Pharma Fertigung GmbH & Co. KG in China Hospital, 2014 Manufacturing Schedule of Adalimumab Generic Drug Prospect of China Adalimumab Market The following enterprises and people are recommended to purchase this report: ...
March 2014
40 pages
Investigation Report on China Pregabalin Market, 2009-2018
US$ 1,800.00
... China. According to CRI's market investigation, the sales revenue of Lyrica in Chinese sample hospital market grew over 100 times from 2010 to 2013. ... incidence of epilepsy is doomed to increase, which leads to a bright future for pregabalin market in China. Through this report, the readers can acquire the ...
March 2014
40 pages
Investigation Report on China Epoetin Alfa Market, 2009-2018
US$ 1,800.00
... by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative ... space for EPO used in anemia after chemotherapy in China. Originally developed by Amgen Inc., epoetin alfa was approved to the U.S. in June 1989 by ...
March 2014
40 pages
Investigation Report on China Imatinib Market, 2009-2018
US$ 1,800.00
... approved to China in 2002 to treat CML and GIST. Its market size keeps increasing after its launch. According to CRI's investigation on sample ... Hospital Market Incidence of CML in China Manufacturing Schedule of Imatinib Generic Drug Prospect of China Imatinib Market The following enterprises and people ...
March 2014
40 pages
Investigation Report on China Aripiprazole Market, 2009-2018
US$ 1,800.00
... the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year. Schizophrenia ... in Different Dosage Forms in China Hospital Market Prospect of China Aripiprazole Market The following enterprises and people are recommended to purchase this ...
March 2014
40 pages
HIV Vaccine Market Opportunity & Clinical Pipeline Analysis
US$ 2,000.00
... promising. “HIV Vaccine Market Opportunity & Clinical Pipeline Analysis” Report Highlights: Introduction to HIV Vaccine & Mechanism Global HIV Incidence Scenario R&D Funding Scenario for HIV Vaccine FDA Regulatory Framework HIV Vaccine Clinical Trial by Phase & Country HIV Vaccines in Development Phase ...
March 2014
330 pages
Investigation Report on China Enoxaparin Sodium Market, 2009-2018
US$ 1,800.00
... , and treat unstable angina and non-Q-wave myocardial infarction. Enoxaparin sodium generic drugs produced by Sandoz and Amphastar Pharm have ... Market Production Status of Enoxaparin Sodium Generic Drug in China Major Enoxaparin Sodium Manufacturers in China Prospect of China Enoxaparin Sodium Market The ...
February 2014
40 pages
Investigation Report on China Pemetrexed Market, 2009-2018
US$ 1,800.00
... value keeps increasing year after year. The CAGR of sales value of pemetrexed was 50.6% from 2004 to 2011. The sales value was only ... China Hospital Market Incidence of Cancer in China Manufacturing Schedule of Pemetrexed generic drug Prospect of China Pemetrexed Market The following enterprises and people ...
February 2014
40 pages
Indonesia Pharmaceuticals Industry Report - H2, 2013
US$ 475.00
... for this low figure. Hence, immense potential exists for growth in Indonesia’s pharmaceutical sector. However, the sector is often plagued by regulatory flip- ... 2012, a single physician served 4,900 citizens in the country. The government of Indonesia has targeted to bring down this figure to 2,500 at the end ...
February 2014
31 pages
Vitamin Price in China
US$ 2,979.00
... benchmarking research studying the cost structure of Chinese vitamin C and the competitiveness of major Chinese players. ... set up the model and verify afterwards. The breakeven price of Chinese products is concluded. The aim of ... as how to penetrate the ever-increasing China market and how to catch the maximum ...
February 2014
6 pages
Investigation Report on China Bevacizumab Market, 2009-2018
US$ 1,800.00
... remedy. Public data shows that the global sales value of bevacizumab in 2012 exceeded USD 6.3 billion, ranking the fourth among the ... Dosage Forms in Hospital Market in China Incidence of Cancer in China Manufacturing Schedule of Bevacizumab generic drug Prospect of China Bevacizumab Market The author ...
February 2014
40 pages
Investigation Report on China Duloxetine Market, 2009-2018
US$ 1,800.00
... increasing, which nearly reached USD 5 billion in 2012. The success of duloxetine sales also comes from its persistent exploration and study ... in Different Dosage Forms in China Hospital Market Prospect of China Duloxetine Market The author recommends the report to the following: Antidepressant APIs ...
February 2014
40 pages
Value-driven Pharma: Integrating health outcomes across the product lifecycle
US$ 595.00
... pharma companies truly integrating health outcome values into product development or merely paying lip-service? In a rare and comprehensive insight into thriving in the "Outcomes Era", Value-driven Pharma: Integrating health outcomes across ... been shaped by economics. In Value-driven Pharma: Integrating health outcomes across the product lifecycle, you will: Understand the importance of endorsing a comprehensive approach to health outcomes from the earliest ...
February 2014
44 pages
Stakeholder Perspectives: Innovation within the Biopharma Industry
US$ 2,495.00
... all of the ‘low hanging fruit’ have been taken there is another perspective: that there is plenty of fruit left on the tree and companies ... company, patient advocacy group or regulatory body, this report Stakeholder Perspectives: Innovation within the Biopharma Industry provides a thought provoking assessment ...
February 2014
99 pages
Investigation Report on China Valsartan Market, 2009-2018
US$ 1,800.00
... can acquire the following information: Market Share of Major Valsartan Manufacturers in Sampling Hospitals in China Sales price of valsartan in hospital market in China Major valsartan enterprises in China Market share of valsartan by dosage form in hospital market in China Prospect of China valsartan ...
February 2014
40 pages
India Pharmaceutical Industry Report - H2, 2013
US$ 475.00
... China, Japan, and the United States. Over the last decade, India’s pharmaceutical and health care sector has made great strides. ... and health care sector witnessed a challenging period in 2013. The domestic pharmaceutical market grew by 9% in 2013, having grown by 12% in 2012. The notification of Drug Prices ...
February 2014
37 pages
Europe Orphan Drug Market Outlook 2018
US$ 1,200.00
... orphan drugs. “Europe Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to Europe orphan drug market: Europe Orphan Drug Market Overview Orphan Drug Designation Criteria Market Specific Reimbursement Policy & Regulatory Framework Europe ...
February 2014
134 pages
US Orphan Drug Market Outlook 2018
US$ 1,200.00
... . “US Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to US orphan drug market: US Orphan Drug Market Overview Orphan Drug Designation Criteria Market Specific Reimbursement Policy & Regulatory Framework US Orphan Drug ...
February 2014
160 pages
Global Radiopharmaceuticals Market Insight
US$ 2,200.00
... . “Global Radiopharmaceuticals Market Insight” Report Highlights Global Radio Pharmaceuticals Market Overview by Region arget Patient Base by Region Radiopharmaceuticals Market Regulation for US, Europe & Canada Radioisotopes Used in Radiopharmaceuticals Radiopharmaceutical Clinical Pipeline Insight ...
February 2014
450 pages
The US Specialty Pharmaceutical Market Report: 2013 Edition
US$ 800.00
... that address the unmet need of the patients as the specialty pharmaceutical market has the ability to sustain the high cost of these ... sluggish pace of innovation and inappropriate use of therapeutic drugs. The specialty pharmaceutical market witnesses fierce competition with numerous top notch players; such ...
January 2014
77 pages
China Pharmaceuticals Industry Report - H2, 2013
US$ 475.00
This report reviews the current trends and market outlook in China’s pharmaceuticals and health care industry. It also discusses the stock ... rural areas is trending up. Nevertheless, public health care expenditure as percentage of total GDP in China still trails many developed economies like the United States, ...
January 2014
34 pages
Global Trends and Developments in Enzymes
US$ 2,000.00
... product categories in which enzymes are used, regional analysis and opportunities for future growth of enzymes. Euromonitor International's Global Trends and Developments in Enzymes global briefing offers a comprehensive guide to the Ingredients market at an international level. It highlights the major ...
January 2014
45 pages
Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis
US$ 2,873.00
... Pipeline Analysis The report entitled Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis published in January 2014 is based on the evaluation of more ... arising from new site-specific and from polymer/nanoparticel-based conjugation systems and the most promising new payloads for ADCs. ...
January 2014
347 pages
Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma
US$ 2,500.00
... : NHI price cut, Japan generic opportunity, Prograf, Xtandi, Isavuconazole, Myrbetriq, Astellas, Chugai, Actemra, Perjeta, biosimilar, Kadcyla, breast cancer, prostate cancer, MPDL3280A, Daiichi Sankyo, Edoxaban , Ranbaxy, Dainnipon Sumitomo, Dainnipon, cancer stem cell inhibitor, BBI-608, Latuda, DS-3025 ...
January 2014
141 pages
Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU
US$ 2,500.00
... melanoma and breast cancer from major pharmaceutical companies. Many of them are ... high premium in speculation of getting acquired (ex. Roche-Alexion). Going forward, Economies of Scale will ... repurchase program and dividend policy. Global Biopharmaceutical Outlook 2014-Global Pharma, released by MP Advisors ...
January 2014
113 pages
World Drugs of Abuse Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles, of Key Players
US$ 6,800.00
... start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ... , controls, calibrators and others. “2014 Analysis of the Global Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and ...
January 2014
318 pages
Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech
US$ 2,500.00
... : Acorda, Alexion, Amgen, Biogen Idec, Celgene, Gilead, Regeneron, Vertex, ACOR, ALXN, AMGN, BIIB, CELG, GILD, REGN, VRTX, Soliris, Eculizumab, Asfotase alfa, Onyx, Kyprolis, RRMM, Denosumab, Prolia, XGEVA, Enbrel, Neupogen/ Neulasta, Biosimilar, Ampyra, Multiple Sclerosis, TECFIDERA, BG-12, PLEGRIDY, Gazyva ...
January 2014
145 pages
Europe Alzheimer's Disease Drug Pipeline Analysis
US$ 1,500.00
... / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Europe Alzheimer’s Disease Drug Pipeline by Clinical Phase: Research: 19 Preclinical: 49 Clinical: 1 Phase-I: 25 Phase-I/II: 2 Phase-II: 26 Phase-II/III: 2 Phase-III: 5 Preregistration: 2 Marketed: 10 Unknown: 1
January 2014
265 pages
US Cancer Vaccine Pipeline Analysis
US$ 1,500.00
... for entry. Constituting almost 50% of the global pie, the US cancer vaccine market was estimated to be worth USD 14 Billion in 2012. With close ... cancer every year, this market is expected to o reach USD 20 billion by 2020. “US Cancer Vaccine Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...
January 2014
300 pages
Europe Parkinson’s Disease Drug Pipeline Analysis
US$ 1,000.00
... for Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Europe Parkinson’s Disease Drug Pipeline by Clinical Phase: Research: 12 Clinical: 26 Phase-I: 14 Phase-I/II: 2 Phase-II: 6 Phase-II/III: 1 Phase-III: 3 Preregistration: 1 Marketed: 18
January 2014
199 pages
US Skin Cancer Drug Pipeline Analysis
US$ 1,200.00
... Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Number of Skin Cancer Drug in Pipeline by Clinical Phase: Research: 3 Preclinical: 29 Clinical: 5 Phase 0: 1 Phase-I: 29 Phase-I/II: 18 Phase-II: 41 Phase-III: 13 Registered: 4 Marketed: 18 Unknown: 1
January 2014
310 pages
Japan Cancer Drug Pipeline Analysis
US$ 1,500.00
... for the pharma companies in their every-day decision making. “Japan Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... to identify and analyze the available investment opportunity in the Japan cancer drug market based upon development process. Following parameters for ...
January 2014
557 pages
Europe Lung Cancer Drug Pipeline Analysis
US$ 1,200.00
... identify and analyze the available investment opportunity in the Europe lung cancer drug market based upon development process. Following parameters for ... drug profile in development phase are covered in “Europe Lung Cancer Drug Pipeline Analysis” research report: Drug Profile Overview Alternate Names for ...
January 2014
340 pages
Europe Orphan Drug Pipeline Analysis 2014
US$ 2,400.00
... in the Europe orphan designated drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Europe Orphan Drug Pipeline Analysis 2014” research report: Drug Profile Overview Active Indication ...
January 2014
1430 pages
